As of 05 Nov 2026 04:39 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2026/041 (01 Sep 2026): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Methylprednisolone (Medrone®) 100mg tabletsaffected product · inferred from phrasing | Out of stock, as stated | w/c 5 October 2026precision: a stated week · window end 11 Oct 2026, derived from “w/c 5 October 2026” | notice of 01 Sep 2026 |
| Methylprednisolone 500mg and 1000mg powder for solution for injectionsnamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 01 Sep 2026 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Methylprednisolone 500mg and 1000mg powder for solution for injections — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Methylprednisolone
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (chemical name), confidence 0.85 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
Notified short 2 times on record since 2022 — a recurring shortage spanning 4.0 years. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 01 Sep 2026 | Medicine Supply Notification: Methylprednisolone (Medrone®) 100mg tablets | Supply notification | Tier 2 | MSN/2026/041 |
| 25 Aug 2022 | Medicine Supply Notification: Methylprednisolone (Medrone®) 4mg tablets | Supply notification | Tier 2 | MSN/2022/072 |
Also recorded under
Bracketed names seen in this medicine's notice titles: medrone. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2026)31 Methylprednisolone (Medrone®) 100mg tablets · issued 04 Sep 2026 · valid until w/c 5 October 2026, as stated · matched by name PDF ↗